We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+4.63%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+763.65%
AUM
$77.1B
AUM Growth
-$1.68B
(-2.1%)
Cap. Flow
-$2.68B
Cap. Flow
% of AUM
-3.48%
Top 10 Holdings %
Top 10 Hldgs %
16.75%
Holding
3,716
New
704
Increased
979
Reduced
1,056
Closed
911
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$626M |
| 2 |
Warner Bros
WBD
|
+$447M |
| 3 |
Apple
AAPL
|
+$436M |
| 4 |
RTX Corp
RTX
|
+$434M |
| 5 |
Constellation Brands
STZ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$502M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$436M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$415M |
| 5 |
Electronic Arts
EA
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.75% |
| 2 | Industrials | 9.36% |
| 3 | Consumer Discretionary | 8.52% |
| 4 | Healthcare | 7.75% |
| 5 | Financials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Eastman Chemical
EMN
$7.69B
| $1.34M | ﹤0.01% |
17,593
+13,195
| +300% | +$951K |
|
|
AUTL
1877
Autolus Therapeutics
AUTL
$389M
| $1.34M | ﹤0.01% |
+971,691
| New | +$1.48M |
|
1878
Olema Pharmaceuticals
OLMA
$977M
| $1.34M | ﹤0.01% |
89,671
-77,637
| -46% | -$1.73M |
|
1879
Atlanta Braves Holdings Series A
BATRA
$3.51B
| $1.33M | ﹤0.01% |
28,277
+627
| +2% | +$28.6K |
|
1880
Lightbridge
LTBR
$251M
| $1.33M | ﹤0.01% |
+124,980
| New | +$1.74M |
|
1881
Canadian Solar
CSIQ
$932M
| $1.33M | ﹤0.01% |
96,184
+76,203
| +381% | +$1.45M |
|
1882
Waste Management
WM
$95B
| $1.33M | ﹤0.01% |
5,796
-124,039
| -96% | -$28.5M |
|
1883
Baytex Energy
BTE
$2.96B
| $1.32M | ﹤0.01% |
295,953
+133,705
| +82% | +$493K |
|
1884
Semtech
SMTC
$9.65B
| $1.32M | ﹤0.01% |
17,199
-450,141
| -96% | -$37M |
|
1885
CALL
Norwegian Cruise Line
NCLH
$9.53B
| $1.32M | ﹤0.01% |
70,500
-92,600
| -57% | -$2.02M |
|
1886
PUT
BHP
BHP
$211B
| $1.32M | ﹤0.01% |
18,100
-15,100
| -45% | -$1.07M |
|
1887
CALL
Regeneron Pharmaceuticals
REGN
$72.9B
| $1.31M | ﹤0.01% |
1,700
-10,300
| -86% | -$7.89M |
|
1888
PUT
Accenture
ACN
$106B
| $1.31M | ﹤0.01% |
6,600
+4,600
| +230% | +$1.07M |
|
1889
Simon Property Group
SPG
$76.4B
| $1.31M | ﹤0.01% |
7,015
+2,129
| +44% | +$406K |
|
|
SGMO
1890
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.31M | ﹤0.01% |
+5,288,097
| New | +$2.1M |
|
1891
Organon & Co
OGN
$3.56B
| $1.31M | ﹤0.01% |
+217,900
| New | +$1.64M |
|
1892
SoundHound AI
SOUN
$2.48B
| $1.3M | ﹤0.01% |
189,171
+150,252
| +386% | +$1.3M |
|
1893
OceanFirst Financial
OCFC
$1.71B
| $1.29M | ﹤0.01% |
+71,722
| New | +$1.32M |
|
1894
CALL
VanEck Oil Services ETF
OIH
$1.97B
| $1.29M | ﹤0.01% |
3,200
+1,600
| +100% | +$586K |
|
1895
Critical Metals Corp
CRML
$754M
| $1.29M | ﹤0.01% |
162,194
+146,792
| +953% | +$1.69M |
|
1896
Cencora
COR
$62B
| $1.28M | ﹤0.01% |
4,072
-14,580
| -78% | -$5.09M |
|
|
DHIL
1897
DELISTED
Diamond Hill
DHIL
| $1.28M | ﹤0.01% |
7,427
+4,568
| +160% | +$783K |
|
1898
AMN Healthcare
AMN
$1.35B
| $1.28M | ﹤0.01% |
69,686
-21,649
| -24% | -$412K |
|
1899
CALL
Blackstone
BX
$104B
| $1.28M | ﹤0.01% |
11,100
+2,000
| +22% | +$260K |
|
1900
CALL
The Mosaic Company
MOS
$7.19B
| $1.27M | ﹤0.01% |
50,000
-85,700
| -63% | -$2.35M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Balyasny Asset Management held 3,716 positions worth $77.1B, down 2.1% from $78.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Balyasny Asset Management withdrew a net $2.68B in Q1 2026, closing 911 positions and reducing 1,056 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Balyasny Asset Management opened a new position in Silicon Laboratories worth $257M.
- Balyasny Asset Management's largest Q1 2026 buy was Silicon Laboratories: 1,233,893 shares worth $257M.
- Balyasny Asset Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $626M increase.
- Balyasny Asset Management's biggest Q1 2026 reduction was Microsoft, cutting an estimated $502M.
- Balyasny Asset Management fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.13B.
- Balyasny Asset Management's ten largest holdings make up 17% of its $77.1B portfolio in Q1 2026.
- Balyasny Asset Management opened 704 new positions and closed 911 in Q1 2026.
- Balyasny Asset Management's portfolio value fell 2.1% quarter-over-quarter to $77.1B.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.